Description/achievement of initiative
The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) represents leading research-based pharmaceutical companies and national industry associations worldwide. IFPMA already plays a leadership and advocacy role within the research based pharmaceutical industry in promoting awareness and encouraging engagement vis-à-vis women's and children's health. IFPMA commits to continue to advocate for policies to support access to medicines and support increased attention, engagement, and collaboration in these important global health areas within and with the global pharmaceutical industry. In low and middle income countries, the industry works to reduce mortality and morbidity, and to improve access to health care and medicines by supporting a large number of philanthropic or not-for-profit partnership programs. IFPMA member companies have more than 200 projects in place, worth an estimated US $9.2 billion that address the health-related Millennium Development Goals. Nearly half of these programs focus on women and children's health, and their number has been growing over the last several years.
As part of this commitment IFPMA will publish a special publication, "Women's & Children's Health Partnerships for the Developing World," which contains a selection of access, education, and capacity building programs addressing women's and children's health, to which IFPMA members conduct or contribute.
Arrangements for Capacity-Building and Technology Transfer
Coordination mechanisms/governance structure
IFPMA member companies have more than 200 projects in place, worth an estimated US $9.2 billion that address the health-related Millennium Development Goals.
Sustainable Development Goals and targets
Resources devoted to implementation
Financing (in USD)